Autism Spectrum Disorders (ASD): From Diagnosis to Management
- Corresponding Author:
- Vasco Azevedo
Depto de Biologia Geral, ICB/UFMG. Av. Antonio Carlos
6627 Pampulha, Belo Horizonte, Minas Gerais, Brazil, CP 486 CEP 31270-901
E-mail: [email protected]
Received Date: December 30, 2014; Accepted Date: January 14, 2015; Published Date: January 21, 2015
Citation: Ali A, Bakhtiar SM, Azevedo V (2015) Autism Spectrum Disorders (ASD): From Diagnosis to Management. J Mol Genet Med 9:154. doi: 10.4172/1747-0862.1000154
Copyright: © 2015 Ali A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Autism spectrum disorders (ASD) is a complex heterogeneous neuro-developmental disorders with varying degrees of severity that can cause significant social, communication and behavioral challenges. ASD research has received considerable attention and continues to be focused because of limited options available for its successful management. The detail understanding of the ASD etiology has now been progressed to encompass genetic, epigenetic, neurological, hormonal, and environmental factors that may affect the individual symptoms of the patients with ASD. The diagnosis of ASD is not that easy since there is no clinical test, such as blood test, available for diagnosis. Specific set of genetic and epigenetic biomarkers represented by a characterized phenotype can respond efficiently to the treatment with a specific drug or intervention. Nevertheless, children and young people with ASD have higher chances of developing unbearable side effects from the use of medications. The general etiology (genetic and epigenetic) and associated symptoms, biomarkers and treatment options of autism are briefly discussed in this article.